Home > National Drug Code (NDC) > Adenovirus Type 4 and Type 7 Vaccine, Live, Oral

Adenovirus Type 4 and Type 7 Vaccine, Live, Oral - 51285-138-50 - (Adenovirus Type 4 and Type 7 Vaccine, Live, Oral)

Alphabetical Index


Drug Information of Adenovirus Type 4 and Type 7 Vaccine, Live, Oral

Product NDC: 51285-138
Proprietary Name: Adenovirus Type 4 and Type 7 Vaccine, Live, Oral
Non Proprietary Name: Adenovirus Type 4 and Type 7 Vaccine, Live, Oral
Active Ingredient(s):    & nbsp;   Adenovirus Type 4 and Type 7 Vaccine, Live, Oral
Administration Route(s):
Dosage Form(s): KIT
Coding System: National Drug Codes(NDC)

Labeler Information of Adenovirus Type 4 and Type 7 Vaccine, Live, Oral

Product NDC: 51285-138
Labeler Name: Teva Women's Health, Inc.
Product Type: VACCINE
FDA Application Number: BLA125296
Marketing Category: BLA
Start Marketing Date: 20110531

Package Information of Adenovirus Type 4 and Type 7 Vaccine, Live, Oral

Package NDC: 51285-138-50
Package Description: 1 KIT in 1 CARTON (51285-138-50) * 100 TABLET, COATED in 1 BOTTLE (51285-174-02) * 100 TABLET, COATED in 1 BOTTLE (51285-175-02)

NDC Information of Adenovirus Type 4 and Type 7 Vaccine, Live, Oral

NDC Code 51285-138-50
Proprietary Name Adenovirus Type 4 and Type 7 Vaccine, Live, Oral
Package Description 1 KIT in 1 CARTON (51285-138-50) * 100 TABLET, COATED in 1 BOTTLE (51285-174-02) * 100 TABLET, COATED in 1 BOTTLE (51285-175-02)
Product NDC 51285-138
Product Type Name VACCINE
Non Proprietary Name Adenovirus Type 4 and Type 7 Vaccine, Live, Oral
Dosage Form Name KIT
Route Name
Start Marketing Date 20110531
Marketing Category Name BLA
Labeler Name Teva Women's Health, Inc.
Substance Name
Strength Number
Strength Unit
Pharmaceutical Classes

Complete Information of Adenovirus Type 4 and Type 7 Vaccine, Live, Oral


General Information